ATE172114T1 - Pharmazeutische zusammensetzung, die carbachol und andere cholinerge substanzen enthält - Google Patents

Pharmazeutische zusammensetzung, die carbachol und andere cholinerge substanzen enthält

Info

Publication number
ATE172114T1
ATE172114T1 AT92918041T AT92918041T ATE172114T1 AT E172114 T1 ATE172114 T1 AT E172114T1 AT 92918041 T AT92918041 T AT 92918041T AT 92918041 T AT92918041 T AT 92918041T AT E172114 T1 ATE172114 T1 AT E172114T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
composition containing
carbachol
cholinergic
cholinergic substances
Prior art date
Application number
AT92918041T
Other languages
English (en)
Inventor
Rudolph Wolfgang Hahnenberger
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Application granted granted Critical
Publication of ATE172114T1 publication Critical patent/ATE172114T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AT92918041T 1991-08-13 1992-08-07 Pharmazeutische zusammensetzung, die carbachol und andere cholinerge substanzen enthält ATE172114T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9102340A SE9102340D0 (sv) 1991-08-13 1991-08-13 Pharmaceutical composition containing carbachol and othercholinergic substances

Publications (1)

Publication Number Publication Date
ATE172114T1 true ATE172114T1 (de) 1998-10-15

Family

ID=20383456

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92918041T ATE172114T1 (de) 1991-08-13 1992-08-07 Pharmazeutische zusammensetzung, die carbachol und andere cholinerge substanzen enthält

Country Status (14)

Country Link
US (1) US5679713A (de)
EP (2) EP0661968B1 (de)
JP (1) JPH06509801A (de)
AT (1) ATE172114T1 (de)
AU (1) AU671805B2 (de)
CA (1) CA2114239C (de)
DE (1) DE69227324T2 (de)
DK (1) DK0661968T3 (de)
ES (1) ES2123005T3 (de)
FI (1) FI108516B (de)
HU (1) HU221592B (de)
NO (1) NO306447B1 (de)
SE (1) SE9102340D0 (de)
WO (1) WO1993003718A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL131477A0 (en) * 1997-02-24 2001-01-28 Michael A Kamm Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
EP1051168B1 (de) * 1997-08-08 2006-03-01 Duke University Zusammensetzungen zur vereinfachung von chirurgischen verfahren
US6711436B1 (en) 1997-08-08 2004-03-23 Duke University Compositions, apparatus and methods for facilitating surgical procedures
US6395758B1 (en) * 1998-08-14 2002-05-28 Gpi Nil Holdings, Inc. Small molecule carbamates or ureas for vision and memory disorders
US7220422B2 (en) * 2003-05-20 2007-05-22 Allergan, Inc. Methods and compositions for treating eye disorders
US8299079B2 (en) 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
CA2780256A1 (en) 2009-11-12 2011-05-19 Acacia Pharma Limited Use of bethanechol for treatment of xerostomia
TW201637648A (zh) * 2015-04-03 2016-11-01 參天製藥股份有限公司 淚腺藥物遞輸系統

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2185220A (en) * 1938-08-17 1940-01-02 Smith Kline French Lab Medicinal agent
GB1386864A (en) * 1972-02-11 1975-03-12 Avicon Inc Micro-crystalline collage-containing pharmaceutical compositions useful for topical applications
JPH02500360A (ja) * 1986-07-28 1990-02-08 リポソーム　テクノロジー，インコーポレイテッド 粘膜組織上での高い保持力を有するリポソーム
US4804539A (en) * 1986-07-28 1989-02-14 Liposome Technology, Inc. Ophthalmic liposomes

Also Published As

Publication number Publication date
NO940400D0 (no) 1994-02-07
CA2114239A1 (en) 1993-02-14
US5679713A (en) 1997-10-21
FI108516B (fi) 2002-02-15
HUT65946A (en) 1994-08-29
DK0661968T3 (da) 1999-06-23
NO306447B1 (no) 1999-11-08
FI940637A0 (fi) 1994-02-11
EP0661968A1 (de) 1995-07-12
NO940400L (no) 1994-02-07
ES2123005T3 (es) 1999-01-01
WO1993003718A1 (en) 1993-03-04
FI940637A (fi) 1994-02-11
HU9400405D0 (en) 1994-05-30
CA2114239C (en) 2003-10-21
EP0661968B1 (de) 1998-10-14
HU221592B (hu) 2002-11-28
AU671805B2 (en) 1996-09-12
SE9102340D0 (sv) 1991-08-13
EP0528776A1 (de) 1993-02-24
JPH06509801A (ja) 1994-11-02
DE69227324D1 (de) 1998-11-19
DE69227324T2 (de) 1999-04-29
AU2463192A (en) 1993-03-16

Similar Documents

Publication Publication Date Title
FR2714670B1 (fr) Nouveau ligand polypeptidique, sa préparation, composition pharmaceutique le contenant, et son application à la production de thrombopoïétine.
DE69319440T2 (de) Herstellung von pharmazeutischen zusammensetzungen, die calcitonin enthalten
RU94043772A (ru) Пропинил-диароматические соединения, фармацевтические и косметические составы на их основе
BG101118A (en) Therapeutical compounds
DE69230500D1 (de) Pharmazeutische Dipeptid Zusammensetzungen und Verwendungsmethoden.
CO4290432A1 (es) Nuevos derivados de pirazinacarboxamida, su preparacion y su utilizacion en medicamentos.
DE69531098D1 (de) Piperidine und pyrrolidine
NO902800D0 (no) Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener.
ES2045182T3 (es) Substancias fisiologicamente activas, un proceso para la preparacion de las mismas y composiciones farmaceuticas que las contienen.
DE69034226D1 (de) Herstellungsverfahren von Huperzine A und deren Analogen und Verbindungen nützlich dazu
DE69129331T2 (de) Verwendung von inosittriphosphat zur zubereitung von medikamenten
ATE172114T1 (de) Pharmazeutische zusammensetzung, die carbachol und andere cholinerge substanzen enthält
ATE305791T1 (de) Pharmazeutische zubereitungen zur behandlung von magengeschwüren
KR920002151A (ko) 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
DE3775854D1 (de) Arzneimittel zur therapie von durch funktionelle und organische basen verursachten gehirnkrankheiten.
MY115795A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them
NO922635D0 (no) Ny anvendelse av benzimidazolin-2-okso-1-karboksylsyrederivater
IL89015A (en) Pharmaceutical compositions containing tetrahydropyridine derivatives, certain such novel compounds and their preparation
DE59405654D1 (de) T-lymphozyten enthaltende pharmazeutische zusammensetzung zur behandlung von infektionen
IT1251993B (it) Composizioni farmaceutiche ad uso orale,a base di esteri di gangliosidi,per il trattamento di neuropatie del sistema nervoso periferico
RU93013421A (ru) Штамм streptococcus faecium м-87, используемый в составе биоконсервантов, а также лечебно-профилактических препаратов
BG95724A (en) Medicaments with analgetic, antiphlogestic and antibacterial effect for external use
AU6725387A (en) Drugs for the treatment and cure of all infectious diseases caused by pathogenic virulent micro-organisms
ATE86242T1 (de) Benzol-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die diese enthalten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee